Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)
Trial details
- Registry ID
- NCT06181136
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A)NCT06181136 | DNLI | Phase 1, Phase 2 | Recruiting | 2032-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |